In addition, in preclinical studies, ASCL1 was shown to stimulate proliferation and migration in SCLC cells by targeting CDK5,18 which is exemplified in our data that ASCL1 high expression is significantly correlated with TNM stage, lymphatic metastasis and nerve invasion. The gene discussed is CDK5; the disease is small cell lung carcinoma.